This legislation aims to make insulin more affordable for individuals aged 26 and younger who are covered by private health insurance plans, addressing the significant financial burden associated with insulin costs for those managing diabetes. It establishes key provisions that require health plans to cover selected insulin products without any deductibles, ensuring that young individuals can access necessary medications without facing excessive out-of-pocket expenses.